EIKO LIFESCIENCES LIMITED (EIKO) reported revenue of ₹16.75 Cr and net profit of ₹1.51 Cr for the quarter ended 2026-06-30. Figures are parsed from the company's filed results.
EIKO fundamentals, Fundamental score 61/100
The statements below are read from EIKO LIFESCIENCES LIMITED’s filed results, 9 filed quarters and 5 fiscal years on record, consolidated basis. Price-linked ratios are computed at the last close, sector medians across the served universe, ownership from the shareholding pattern, and any cell whose input isn’t on record shows a dash, never an estimate.
Latest: Q1 FY26-27 · filed Aug 12, 2026
Sales CAGR · 3Y+131.1%FY18 → FY25
Sales CAGR · 4Y+117.4%FY17 → FY25
PAT CAGR · 3Y—FY18 → FY25
PAT CAGR · 4Y+127.2%FY17 → FY25
Price · 1Y—EOD
Price CAGR · 3Y—EOD
Quarterly resultsConsolidated
₹ Cr
Jun2024
Sep2024
Dec2024
Mar2025
Jun2025
Sep2025
Dec2025
Mar2026
Jun2026Latest
YoYlatest
Sales
10.8
8.16
7.49
11.3
10.7
11.7
12.0
18.3
16.7
+56.4%
10.4
7.73
6.85
9.95
9.20
9.91
10.1
16.1
14.8
+61.0%
Operating profit
0.40
0.42
0.64
1.32
1.51
1.77
1.88
2.29
1.94
+28.2%
OPM %
3.7%
5.2%
8.5%
11.7%
14.1%
15.1%
15.7%
12.5%
11.6%
-2.5 pp
Other income
0.26
0.13
0.09
0.23
0.27
0.26
0.32
0.13
0.41
+54.9%
Interest
0.03
0.04
0.03
0.07
0.05
0.10
0.07
0.12
0.13
+169.9%
Depreciation
0.17
0.16
0.16
0.25
0.25
0.26
0.26
0.25
0.25
-0.0%
Profit before tax
—
0.38
0.57
1.64
1.47
1.67
1.87
2.05
1.96
+33.2%
Tax %
—
25.2%
25.4%
24.0%
24.9%
25.5%
25.5%
25.5%
25.0%
+0.1 pp
Net profit
0.37
0.28
0.42
1.24
1.12
1.28
1.43
1.50
1.51
+35.0%
EPS (₹)
—
—
—
—
0.66
0.78
0.88
0.93
0.91
+37.9%
One column per filed quarter · ₹ crore · YoY = latest vs the same quarter a year back · EPS restated for bonus/split↔ scroll for earlier quarters
Revenue & net profit trend
last 9 quarters
RevenueNet profit
Revenue & net profit — Consolidated9 quarters
Segment results
Needs segment dataSegment results not parsedPer-segment revenue, EBIT margin and YoY arrive once we parse the segment annexure from the filing.
Forensic checksauto-scanned from the filing
Coming soonForensic checks not connectedAuditor opinion, OCF÷PAT, contingent liabilities, related-party share and working-capital days arrive as we parse the notes-to-accounts + cash-flow statement. Promoter-pledge is already on the Holdings tab.
How results moved the priceEOD reaction on the session the market could trade the filing
Avg absolute result-day move ±0.8%· EPS surprise: no estimates source· 6 earlier quarters have no dated filing on record
Q1'27filed Wed 12 Aug 13:48 · traded that sessiongap +0.7%close −0.9%
Q4'26filed Tue 26 May 20:12 · first tradeable session Wed 27 Maygap +1.8%close +0.5%
Q3'26filed Thu 29 Jan 13:48 · traded that sessiongap +1.8%close +0.8%
